ScholarIQanswers from OpenAlex
Université de Montpellier
InstitutionResearch output, impact & collaborations
Université de Montpellier is a institution indexed in ScholarIQ from OpenAlex.
What is known about Université de Montpellier?
ScholarIQrecord summary
Université de Montpellier is a research organisation in Montpellier, FR. OpenAlex records 145,341 works and 9,881,503 citations for it. 25,096 researchers list it as their most recent affiliation.
How many works does Université de Montpellier have?
ScholarIQindexed works
Université de Montpellier has 145,341 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Université de Montpellier have?
ScholarIQcitation count
Université de Montpellier has 9,881,503 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Université de Montpellier?
ScholarIQresearcher count
Université de Montpellier has 25,096 researchers in the ScholarIQ index.
What is the average h-index at Université de Montpellier?
ScholarIQavg h-index
Université de Montpellier has an average h-index of 64.8 in OpenAlex.
What is the ROR of Université de Montpellier?
ScholarIQror
The ROR for Université de Montpellier is on the source record.
What is the OpenAlex record for Université de Montpellier?
ScholarIQopenalex
The OpenAlex for Université de Montpellier is on the source record.
Who are the most-cited researchers behind Université de Montpellier?
ScholarIQtop researchers by citations
What are the most-cited papers on Université de Montpellier?
ScholarIQmost cited works
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
Daniel Aletaha, Tuhina Neogi, Alan J. Silman, Julia Funovits, David T. Felson, Clifton O. Bingham, Neal S. Birnbaum, Gerd R Burmester, Vivian P. Bykerk, Marc D. Cohen, Bernard Combe, Karen H. Costenbader, Maxime Dougados, Paul Emery, Gianfranco Ferraccioli, Johanna M. W. Hazes, Kathryn Hobbs, T. Huizinga, Arthur Kavanaugh, Jonathan Kay, Tore K. Kvien, Timothy Laing, Philip J. Mease, Henri A. Ménard, Larry W. Moreland, Raymond L. Naden, Theodore Pincus, Josef S Smolen, Ewa Stanisławska‐Biernat, Deborah Symmons, Paul P. Tak, Katherine S. Upchurch, Jiří Vencovský, Frederick Wolfe, Gillian Hawker
Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials
Jonathan Emberson, Kennedy R. Lees, Patrick D. Lyden, Lisa Blackwell, Gregory W. Albers, Erich Bluhmki, Thomas Brott, Geoff Cohen, Stephen C. Davis, Geoffrey A. Donnan, James C. Grotta, George Howard, Markku Kaste, Masatoshi Koga, Ruediger von Kummer, Maarten G. Lansberg, Richard I. Lindley, Gordon Murray, Jean‐Marc Olivot, Mark Parsons, Barbara C. Tilley, Danilo Toni, Ḱazunori Toyoda, Nils Wahlgren, Joanna M. Wardlaw, William Whiteley, Gregory J. del Zoppo, Colin Baigent, Peter Sandercock, Werner Hacke
Treating rheumatoid arthritis to target: recommendations of an international task force
Josef S Smolen, D. Aletaha, J. W. J. Bijlsma, Ferdinand C Breedveld, Dimitrios T. Boumpas, G.-R. Burmester, Bernard Combe, M. Cutolo, Maarten de Wit, M Dougados, Paul Emery, Alan Gibofsky, Juan J. Gómez‐Reino, Boulos Haraoui, J. R. Kalden, Edward Keystone, T. K. Kvien, Iain B. McInnes, E. Martín‐Mola, Carlomaurizio Montecucco, M. Schoels, D. van der Heijde
Recommendations on Angiographic Revascularization Grading Standards for Acute Ischemic Stroke
Osama O. Zaidat, Albert J. Yoo, Pooja Khatri, Thomas A. Tomsick, Rüdiger von Kummer, Jeffrey L. Saver, Michael P. Marks, Shyam Prabhakaran, David F. Kallmes, Brian‐Fred Fitzsimmons, J Mocco, Joanna M. Wardlaw, Stanley L. Barnwell, Tudor G. Jovin, Italo Linfante, Adnan Siddiqui, Michael J. Alexander, Joshua A Hirsch, Max Wintermark, Gregory W. Albers, Henry H. Woo, Donald Heck, Michael H. Lev, Richard I. Aviv, Werner Hacke, Steven Warach, Joseph P. Broderick, Colin P. Derdeyn, Anthony J. Furlan, Raul G. Nogueira, Dileep R. Yavagal, Mayank Goyal, Andrew M. Demchuk, Martin Bendszus, David S. Liebeskind
Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study
Jong‐Mu Sun, Lin Shen, Manish A. Shah, Peter C. Enzinger, Antoine Adenis, Toshihiko Doi, Takashi Kojima, Jean‐Philippe Metges, Zhigang Li, Sung‐Bae Kim, Byoung Chul Cho, Wasat Mansoor, Shau-Hsuan Li, Patrapim Sunpaweravong, María Maqueda, Eray Goekkurt, Hiroki Hara, Luís Carlos Moreira Antunes, Christos Fountzilas, Akihito Tsuji, Victor Castro Oliden, Qi Liu, Sukrut Shah, Pooja Bhagia, Ken Kato
How much of the research on Université de Montpellier is open access?
ScholarIQopen access share
75%OPEN ACCESS